BILASTIN Mepha cpr 20 mg 10 pce
7680680020012
CH-68002
R06AX29
07.13.1.
1 / 3
google
Details
- Product number
- 6800201
- CPT
- -
- Packaging group
- 10
- Unit
- Tablette(n)
- Composition
- bilastinum 20 mg, cellulosum microcristallinum, mannitolum, silica colloidalis anhydrica, magnesii stearas, carboxymethylamylum natricum A corresp. natrium 0.21 mg, magnesii aluminii silicas, pro compresso.
Articles (1)
Bilastin-Mepha 20 mg, Tabletten
Tabletten
10
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.21 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 4.15
Specialties list
Yes
Generic
Yes
SL addition date:
01/01/2023
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 68002
- Drug name
- Bilastin-Mepha Tabletten
- Galenic form
- TAB
- ATC Code
- R06AX29
- Authorization status
- Z
- Dispensation category
- D
- First authorization
- 01/11/2021
- Authorization expiration date
- 31/10/2026
- IT number
- 07.13.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BILASTIN Mepha cpr 20 mg 10 pce
- Description (DE)
- BILASTIN Mepha Tabl 20 mg 10 Stk
- Market launch
- 01/11/2021
- Narcotic (BTM)
- No